Global Apheresis Market - Segmented by Applications, Types of Procedures, Technology and Geography - Growth, Trends, and Forecast (2018 - 2023)
The apheresis market is expected to grow, at a CAGR of about 7.7% during the forecast period. Apheresis is primarily accepted as an acute therapeutic method in a variety of diseases, and millions of patients undergo the treatment every year. Today, apheresis is considered as a treatment option for a large number of chronic diseases such as rheumatoid arthritis, cancer, multiple sclerosis, and others. The global blood plasma market is highly competitive consisting of several large conglomerates such as Baxter international.
Growing Demand for Plasma
Platelets are an important component of blood because they are a critical part of the clotting process. They prevent or stop bleeding and are life-saving therapy for patients undergoing chemotherapy for cancer treatment, leukemia, bone marrow transplants, organ transplants and open heart surgery. Chinese patients consumed nearly 300 tonnes of serum albumin in 2016 which is half of the overall global consumption. About 60 per cent of that was imported, and demand is growing at 15 per cent annually. Serum albumin is the main protein constituent in human plasma. This constantly increasing demand for human plasma will lead to a rapid growth in the apheresis market. Other factors that will drive the market in the future include growing number of platelet donors, improving healthcare infrastructure in emerging economies and reimbursement policies.
Lack of Trained Professionals
It is very important for an apheresis facility to have a medical supervisor who should be the medical head of the collection facility. Apheresis donation shares many reactions and injuries with whole blood donation, because of the differences, unique complications also exist. As such issues might arise, the medical head of the collection facility should have qualifications and experience appropriate to the clinical requirements of the facility. Appropriately trained and experienced medical staff should be available immediately for care or advice of the patients undergoing apheresis. Apheresis requires nursing staff with an appropriate level of training and experience. Junior nursing staff will require adequate supervision. An ongoing education program should be in place. Lack of such trained professionals in the current scenario will affect the market growth negatively. Other factors that will slow down the market growth include lack of donor availability & histocompatibility and health risks associated with apheresis.
North America to Maintain Dominance
North America represented the largest regional market, followed by Europe. While North America will continue to dominate the market during the forecast period, the Asia-Pacific region is expected to register the highest growth. The growth of this regional segment is driven by the improving healthcare infrastructure, significant economic development in emerging markets, and rising focus of key market players in this region.
Key Developments in the Market:
December 2017 - Spectral Medical received FDA 510(k) clearance for its Spectral Apheresis Machine designed for use in continuous renal replacement therapy and therapeutic plasma.
Major Players: ASAHI KASEI CORPORATION, B. BRAUN MELSUNGEN AG, CERUS CORPORATION, FRESENIUS SE & CO. KGAA, HAEMONETICS CORPORATION, HEMACARE CORPORATION, KANEKA CORPORATION, KAWASUMI LABORATORIES INC, TERUMO CORPORATION AND THERAKOS INC amongst others.
Reasons to Purchase the Report